Fig. 2From: Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapyROC curve analysis of the predictive value of SUVs on baseline 18F-Alfatide II PET/CT imaging for short-term response to CCRT, revealing a significant AUC of 0.764 (P = 0.018) for TBRP (cutoff value, 6.52)Back to article page